About
This symposium, co-organized by the French Society for Medicinal Chemistry (SCT), Evotec and Institut Pasteur, will cover outstanding innovation and applied state-of-the-art molecular design contributing to advance drug discovery boundaries. Selected themes of the Symposium will be dedicated to “breakthrough” discoveries or innovative technologies/methods and may include the application of machine learning (ML) and artificial intelligence (AI).
PROGRAM
The following speakers have already confirmed their presence:
- Dr Christoph Grebner (Sanofi, Frankfurt)
- Dr Raquel Rodriguez Perez (Novartis, Bale)
- Dr Fredrick Zetterberg (Galecto Biotech, Copenhagen)
- Andreas Luttens (University of Uppsala), winner of the 2022 Evotec prize for Excellence in Molecular Design.
- Dr Stefania Monteleone (Evotec, Abingdon)
- Dr Merveille Eguida (University of Strasbourg)
- Dr Gilles Labesse (CBS, Montpellier)
- Drs Christophe Zimmer and Bogdan Ciambur (Institut Pasteur, Paris)
A precise agenda with titles and abstracts will be available soon.
REGISTRATION
Registration are open ! Click here to register
SCIENTIFIC ORGANIZATION COMMITTEE
- Rebecca Deprez-Poulain, President of the SCT
- Jean-Yves Ortholand, Vice-President of the SCT
- Olivier Sperandio, Group Leader – Institut Pasteur & SCT
- Gilbert Lassalle, SVP Head of Medicinal Chemistry France – Evotec
- Christophe Boldron, VP Head of Molecular Architects France – Evotec
LOCATION
Please note that the access to the Symposium will be at the Vaugirard Entrance of the Institut Pasteur : 205 rue de Vaugirard, 75015 Paris
CONTACT & INFORMATION
For any information please contact Emilie Boutet : emilie.boutet@pasteur.fr
Event on the SCT website